Meta's Muse AI Agent Tops App Charts, Driving Global AI Stock Rally and Sector Rotation in China
On September 22, Chinese A-share markets closed mixed with the Shanghai Composite up 0.06% and turnover reaching 2.14 trillion yuan. AI application stocks surged after Meta's Muse AI agent topped Apple's free app chart, driving Meta's stock up 11% overnight. CPU concept stocks rallied on expectations of increased server demand from AI agent deployment, though gains narrowed. The pharmaceutical sector rose on Moderna's mRNA cancer therapy news. Over 3,000 stocks declined amid rapid sector rotation.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Meta AI Agent Launch Drives Stock Surge; CPU and Vaccine Concepts Rally in Market Recap
In the previous trading session, Chinese markets experienced a volatile session with the STAR 50 index initially surging over 3% before turning negative in the afternoon. Total turnover on Shanghai and Shenzhen exchanges reached 2.14 trillion yuan, up 104 billion yuan from the prior day. AI application-related stocks were strong after Meta's Muse AI agent topped Apple's free app chart, driving Meta's stock up 11% overnight. Separately, TypeSafe AI released its first System One model, Jev, on September 15. This spurred gains in software stocks like Nanwei Software and YANLONG, while CPU concept stocks surged on expectations of increased server CPU demand due to large-scale AI agent deployment, though China Greatwall Technology's afternoon pullback narrowed sector gains. In the pharmaceutical sector, Moderna announced its individualized mRNA neoantigen therapy data will be presented at the 2026 ESMO conference, sending its stock up 12% and boosting Chinese CDMO and innovative drug stocks, with Huaren Pharmaceutical hitting a 20% limit-up for two consecutive days. The real estate sector rebounded after initial weakness, supported by policy signals for urban renewal and strong September home sales data in first-tier cities, with stocks like Wanke A rising over 6% in the afternoon.
Read sourceChina stocks show mixed performance; AI software and hardware diverge; two new stocks surge over 680% on debut
Chinese stock markets ended mixed on September 22, with the Shanghai Composite up 0.06%, the Shenzhen Component down 0.05%, and the ChiNext up 0.01%. Trading volume reached 2.14 trillion yuan, up 104 billion from the previous session, but the market showed signs of 'volume stagnation' as over 3,000 stocks declined. AI-related stocks saw divergence: AI application stocks rallied on Meta's Muse AI agent success, while CPU concept stocks surged initially but later retreated. Two newly listed stocks, N Century and N Zhongsu, surged over 742% and 683% respectively after triggering secondary trading halts. The real estate sector rebounded on policy support and improved home sales data. Analysts noted that the ChiNext and STAR 50 indices gave up key moving averages, and the market's cautious stance ahead of holidays may limit tech stock inflows. The article also highlighted risks of regulatory intervention on speculative stocks.
Read sourceChina stocks end mixed; AI apps, chip stocks rally as over 3,000 shares fall
Chinese stock markets ended mixed on September 22, with the Shanghai Composite Index edging up 0.06% and the Shenzhen Component Index and ChiNext Index closing nearly flat after a midday rally faded. Total turnover on the Shanghai and Shenzhen exchanges reached 2.14 trillion yuan, up 104 billion yuan from the previous session. Over 3,000 stocks declined amid rapid sector rotation. AI application and computing chip stocks were among the few bright spots, with the software ETF tracking an index up nearly 2% and the tech-chip ETF rising 0.4%. The pharmaceutical sector saw multiple stocks hit daily limits following the release of the '15th Five-Year Plan' for the pharmaceutical industry, which emphasizes AI and frontier technologies in drug R&D. The shipping sector weakened. ETF market activity remained high, with total turnover reaching 591.4 billion yuan. Key news items included Changxin Memory Technologies announcing mass production of its fifth-generation DRAM platform, and Meta's AI agent Muse topping Apple's App Store free charts, boosting CPU-related stocks.
Read sourceShow 17 older updatesHide older updates
China's Shanghai Composite Rises for Third Day; AI, Cloud Conference Fuel Tech Rally
China's A-share market showed mixed results on September 22, with the Shanghai Composite Index edging up 0.06% to 3952.13 points, while the Shenzhen Component Index fell slightly. Trading volume remained above 2 trillion yuan for a third consecutive day. The AI application and computing chain led gains, driven by the opening of the 2026 Alibaba Cloud Apsara Conference (云栖大会) in Hangzhou, themed 'Intelligence for Use' and featuring Nvidia as a top partner, and the success of Meta's AI agent Muse topping the US iPhone download chart. The Philadelphia Semiconductor Index surged 4.29% overnight, and AMD's market cap exceeded $1 trillion for the first time. Domestic chipmaker Haiguang Information launched its 1000-series CPU. The Hong Kong tech sector also rose, supported by southbound capital inflows. Vaccine and medical device stocks rebounded, while oil and dividend-yielding sectors declined due to falling international oil prices. Analysts from China Securities, Huatai, and Dongwu Securities offered bullish views on AI-driven semiconductor demand, optical communications, and domestic substitution. The article advises continued focus on AI computing and applications, while cautioning on oil and dividend sectors.
Read sourceChina stocks end mixed; AI and pharma lead gains on CPU rally and Meta Muse popularity
China's A-share market closed mixed on September 22, with the Shanghai Composite edging up 0.06% to 3952.13, the Shenzhen Component flat at 13723.74, and the ChiNext flat at 3399.93. The Beijing Stock Exchange 50 fell 1.08%. Total turnover reached about 2.14 trillion yuan, up 104 billion from the previous session. Gainers outnumbered decliners 2374 to 3030, with 65 stocks hitting the daily limit up and 5 limit down, indicating weak profit-taking sentiment. AI applications and media stocks led gains, driven by Meta's AI agent Muse topping the US iPhone free app downloads for a third consecutive day, and by Alibaba CEO Wu Yongming's pledge at the 2026 Yunqi Conference to fully invest in AI infrastructure. CPU and compute chip stocks also rose after AMD surged 9.9% overnight and Haiguang Information launched its 1000-series CPU. Pharmaceutical stocks gained on mRNA tumor vaccine optimism following Moderna's 12.27% overnight rise. Shipping, tourism, precious metals, and steel sectors declined, pressured by hawkish Fed signals and a stronger dollar.
Read sourceA-Share Market Recap: Indexes Open High, Close Mixed; AI and Pharma Lead Gains
On September 22, China's A-share market saw indexes open higher but close mixed, with the Shanghai Composite edging up 0.06% to 3952.13, the Shenzhen Component down 0.05% to 13723.74, and the ChiNext flat at 3399.93. The STAR 50 rose 0.46%, while the Beijing Stock Exchange 50 fell 1.08%. Total turnover reached approximately 2.14 trillion yuan, up about 104 billion yuan from the prior session. Declining stocks outnumbered advancers 3030 to 2374, with 65 stocks hitting the daily limit up and 5 limit down, indicating weak profit-taking sentiment. AI applications and media sectors led gains, driven by Meta's AI agent Muse topping U.S. iPhone downloads for a third consecutive day and Alibaba CEO Wu Yongming's pledge to invest heavily in AI infrastructure at the 2026 Yunqi Conference. CPU and chip stocks also rose after AMD's market cap surpassed $1 trillion and Intel surged over 12% overnight. In contrast, shipping, tourism, precious metals, and steel sectors declined, pressured by hawkish Fed signals and a stronger U.S. dollar. The pharmaceutical sector was active on mRNA vaccine optimism, with CanSino up 10.05%.
Read sourceChina's AI Application Stocks Surge, Semiconductor Chips Active as Market Turns Over
Chinese A-share markets saw mixed trading on September 22, with the ChiNext index initially surging over 2% before paring gains to close nearly 1% higher. The Shanghai Composite traded in positive territory. Total turnover for the morning session reached 1.43 trillion yuan, up 100.4 billion from the previous session. AI application concept stocks led gains, with companies like Nanwei Software, Zhidu Shares, and Guangyun Technology rising. The sector was boosted by Meta's early-September launch of a consumer AI agent. Semiconductor chip stocks, including computing and end-side chips, were also active. CXO concept stocks strengthened again, driven by a partnership between Eli Lilly and Genscript Biotech, which is expected to increase AI-driven drug development orders. Alibaba CEO Wu Yongming stated at the Apsara Conference that the company will fully invest in AI infrastructure, targeting over 20GW of global data center capacity by 2032. Pingtouge also announced a significant increase in annual shipments of its domestic AI chips. The market is viewed as trending upward with opportunities for dips in hot sectors.
Read sourceChina Stocks Close Lower; AI Drug Discovery, Auto, Agriculture Sectors Active
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index down 0.29%, and the ChiNext Index down 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. The innovative drug and CXO sectors surged following GenScript Biotech's announcement of a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved from the 'algorithm narrative' to the 'clinical realization' phase. The automotive sector rose after GAC Group announced plans to acquire equity from FAW Co., Ltd., making FAW its second-largest shareholder. The agricultural sector was active after the Cyberspace Administration of China and other ministries issued a digital village action plan for 2026-2030. The tourism sector also gained following a cultural and tourism development plan. Precious metals concepts declined. Market sentiment is recovering with increasing trading volume, though sector rotation remains rapid.
Read sourceChina Stocks End Mixed; AI Drug Discovery, Auto, Agriculture Sectors Lead Gains
China's three major stock indices closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite down 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Turnover on the Shanghai and Shenzhen exchanges reached 1.24 trillion yuan in the first half, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged, led by Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech, following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform LiLLY TuneLab. Zheshang Securities noted that AI-driven drug discovery has entered the clinical realization phase. The automotive sector saw sudden gains after GAC Group announced plans to acquire equity from FAW Co., Ltd., making FAW its second-largest shareholder. Agricultural stocks rose on the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). The tourism sector also performed well following the Ministry of Culture and Tourism's 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The market maintained a pattern of oscillation and rotation with increasing trading volume.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge, Auto and Agriculture Sectors Active
Chinese stock markets ended the morning session slightly lower, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks rallied broadly, with Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hitting daily limits, following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities stated AI-driven drug discovery has moved to the 'clinical realization' stage. The automotive sector saw sudden gains, with Ankai Bus, Haima Automobile, and Zotye Auto hitting daily limits after GAC Group announced plans to acquire equity from FAW Co., Ltd. Agricultural stocks like Jinjian Rice Industry and Dunhuang Seed also hit daily limits following a government action plan for digital village development. The tourism sector performed well after a ministry plan for cultural and tourism development. Market hotspots rotated rapidly, with over 3,100 stocks declining overall.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge on AI Drug Discovery News
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined morning trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Over 3,100 stocks declined. The innovative drug sector surged after GenScript Biotech announced a collaboration with Eli Lilly on its AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved from the 'algorithm narrative' to the 'clinical realization' stage. The automotive sector saw unusual upward moves after GAC Group announced plans to acquire equity in a joint venture from FAW Co., Ltd., making FAW its second-largest shareholder. Agriculture stocks rose following the release of a digital village development action plan for 2026-2030. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Market hotspots rotated rapidly, with technology stocks showing internal divergence.
Read sourceChina Stocks Close Lower; Innovative Drugs, Autos, Agriculture Lead Gains
Chinese stock markets closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Sector rotation was rapid, with innovative drug and CXO concept stocks surging collectively following GenScript Biotech's collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved to the 'clinical realization' phase. The automotive sector saw unusual upward momentum after GAC Group announced plans to acquire equity from FAW, making FAW its second-largest shareholder. Agricultural stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). Tourism stocks also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Technology stocks showed internal divergence after leading gains the previous day. Market sentiment is gradually recovering with increasing trading volume.
Read sourceChina Stocks End Lower; Drug, Auto, Agriculture Sectors Rally; Fed Hikes Rates
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan in the morning session. Sector hotspots rotated rapidly, with innovative drug and CXO concepts rallying broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted AI-driven drug discovery has moved from narrative to clinical realization. The automotive sector surged unexpectedly following GAC Group's announcement of a planned equity acquisition from FAW. Agriculture stocks were active after the government issued a digital village development plan. Tourism stocks also gained on a new cultural and tourism plan. On the downside, precious metals concepts adjusted. Separately, Huawei announced the Ascend 960 chip release is moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks Close Lower; Innovative Drugs, Auto, Agriculture Sectors Active
Chinese stock markets ended the morning session slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index down 0.29%, and the ChiNext Index declining 0.12%. Trading volume reached 1.24 trillion yuan in the first half, up 79.5 billion yuan from the previous session, though over 3,100 stocks declined. Sector rotation was rapid, with innovative drug and CXO concept stocks surging collectively after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' phase, with efficiency improvements stimulating demand for molecular validation. The automotive sector saw sudden upward movements following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. The agriculture sector rebounded after the government issued a digital village development action plan. The tourism sector also performed well following the Ministry of Culture and Tourism's 15th Five-Year Plan. Market sentiment is slowly recovering with increasing trading volumes, and investors are advised to focus on structural opportunities and sector rotation.
Read sourceChina Stocks Fluctuate; Innovative Drugs, Autos, Agriculture Active; Fed Hikes Rates
Chinese stock markets experienced a volatile morning session on September 17, with all three major indices closing slightly lower despite an initial surge. The Shanghai Composite Index fell 0.36%, the Shenzhen Component Index dropped 0.29%, and the ChiNext Index declined 0.12%. Combined turnover reached RMB 1.24 trillion, up from the previous session. Sector rotation was rapid, with innovative drug and CXO concepts rallying broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform. Zheshang Securities noted that AI-driven drug discovery has entered a 'clinical realization' phase. The automotive sector saw sudden upward momentum following GAC Group's announcement of a planned equity acquisition from FAW. Agricultural stocks were active after the release of a national digital village development plan. Tourism stocks also performed well. Meanwhile, Huawei announced the Ascend 960 chip release has been moved up to Q1 2027. The Federal Reserve raised interest rates by 25 basis points, the first hike since July 2023.
Read sourceChina Stocks Close Lower; AI Drug Discovery, Auto, Agriculture Sectors Rally on News Catalysts
China's three major indices closed slightly lower on September 17 after a morning session of volatile consolidation, with the Shanghai Composite falling 0.36%, the Shenzhen Component dropping 0.29%, and the ChiNext Index declining 0.12%. Combined trading volume reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. Innovative drug and CXO concept stocks surged collectively after GenScript Biotech announced a collaboration with Eli Lilly's AI/machine learning drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved to the 'clinical realization' stage, with efficiency gains expected to boost demand for molecular validation. The automotive sector saw unusual upward momentum following GAC Group's announcement of a planned equity acquisition from FAW Co., Ltd. Agriculture stocks rose after the Cyberspace Administration of China and other ministries issued a digital village development action plan. Tourism stocks also performed well following the Ministry of Culture and Tourism's 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. Market hotspots rotated rapidly, but trading volume increased, indicating gradual recovery in sentiment.
Read sourceChina Stocks End Lower; Innovative Drugs Surge on AI Drug Discovery Deal, Auto Sector Active
Chinese equities closed slightly lower on September 17, with the Shanghai Composite falling 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index losing 0.12%. Morning session trading volume reached 1.24 trillion yuan, up 79.5 billion from the prior day. Innovative drug and CXO stocks surged after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform, LiLLY TuneLab. Zheshang Securities commented that AI-driven drug discovery has moved from the 'algorithm narrative' to the 'clinical realization' phase. The automotive sector saw unusual upward moves after GAC Group announced plans to acquire equity in a joint venture from FAW Co., Ltd. Agricultural stocks rose following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). The tourism sector also gained on the Ministry of Culture and Tourism's 15th Five-Year Plan. Precious metals stocks fell. The report notes rapid sector rotation and a slow recovery in market sentiment.
Read sourceChina Stocks Close Lower; Innovative Drugs, Auto, Agriculture Sectors Active
Chinese stock markets experienced a volatile morning session on September 17, with the three major indices closing slightly lower despite an initial surge. The ChiNext Index briefly rose over 1% before retreating. Half-day trading volume in Shanghai and Shenzhen reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session, with over 3,100 stocks declining. Sector rotation was rapid: innovative drug and CXO concepts strengthened collectively, with Jinshi Yaoye, Baihua Pharmaceutical, and Nanhua Biotech hitting daily limit-ups, following GenScript's collaboration with Eli Lilly's AI drug discovery platform. The automotive sector saw unusual upward movements, with Ankai Bus, Haima Automobile, and Zotye Auto hitting limit-ups after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agriculture sector remained active, with Jinjian Rice Industry and Dunhuang Seed hitting limit-ups, supported by a new digital village action plan. Precious metals concepts declined. Separately, Huawei's Wang Tao announced the Ascend 960 chip release was moved up to Q1 2027, and the Federal Reserve raised interest rates by 25 basis points to 3.75%-4.00%, the first hike since July 2023.
Read sourceChina Stocks End Mixed; AI Drug Stocks Surge on GenScript-Eli Lilly Deal, Auto Sector Active
China's three major stock indices closed slightly lower on September 17 after a volatile morning session, with the Shanghai Composite down 0.36%, the Shenzhen Component down 0.29%, and the ChiNext Index down 0.12%. Half-day trading volume on the Shanghai and Shenzhen exchanges reached 1.24 trillion yuan, up 79.5 billion yuan from the previous session. The innovative drug and CXO sectors rallied broadly after GenScript Biotech announced a collaboration with Eli Lilly using its AI/machine learning drug discovery platform LiLLY TuneLab. Zheshang Securities noted that AI-driven drug development has entered the 'clinical realization' phase, with wet-lab experiments being a key bottleneck. The automotive sector saw sudden upward momentum after GAC Group announced plans to acquire equity from FAW Co., making FAW its second-largest shareholder. Agricultural stocks rose following the release of the Digital Village Development Action Plan (2026-2030) by Chinese regulators. The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The market maintained a rotation pattern with gradually increasing trading volumes.
Read sourceChina Stocks Close Lower; Innovative Drugs Surge on AI Drug Discovery News
Chinese stock markets closed slightly lower on September 17, with the Shanghai Composite Index falling 0.36%, the Shenzhen Component Index dropping 0.29%, and the ChiNext Index declining 0.12%. Combined turnover reached 1.24 trillion yuan in the morning session, up 79.5 billion yuan from the previous day. Innovative drug and CXO concept stocks rallied broadly after GenScript Biotech announced a collaboration with Eli Lilly's AI drug discovery platform, LiLLY TuneLab. Zheshang Securities stated that AI-driven drug discovery has moved to the 'clinical realization' stage, with wet-lab experiments being the bottleneck, and efficiency improvements from AI will spur demand for molecular validation. The automotive sector saw sudden gains after GAC Group announced plans to acquire equity from FAW Co., Ltd. The agricultural sector was active following the release of the Action Plan for High-Quality Development of Digital Villages (2026-2030). The tourism sector also performed well after the Ministry of Culture and Tourism issued its 15th Five-Year Plan. Over 3,100 stocks declined, with precious metals concepts falling. The market remains in a rotation and consolidation pattern with increasing trading volume.
Read source